Novo Nordisk A/S (NVO) NYSE

45.56

+0.045(+0.10%)

Updated at May 29 12:28PM

Currency In USD

Valuation

Market Cap1.44T
Enterprise Value1.54T
P/E Ratio10.66
PEG Ratio0.64
Price/Sales Ratio3.97
Price/Book Ratio6.4
Enterprise/Revenue4.35
Enterprise/EBITDA7.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.37
Operating Margin0.45

Management Effectiveness

Return On Assets0.22
Return On Equity0.66

Income Statement

Revenue309.06B
Revenue/Share73.79
Gross Profit250.28B
EBITDA156.73B
Net Income102.43B
Diluted EPS23.03

Balance Sheet

Total Cash21.63B
Total Cash/Share4.87
Total Debt146.38B
Total Debt/Equity0.72
Current Ratio0.79
Book Value Per Share45.71

Price History

52-Week Change-34.48
52-Week High81.44
52-Week Low35.12
Moving Average 50 Days40.95
Moving Average 200 Days48.99

Statistics

Average Volume17.18M
Shares Outstanding4.44B
% Held by Institutions7.32

Dividend And Splits

Trailing Annual Dividend Rate11.7
Trailing Annual Dividend Yield4
Payout Ratio0.42
Last Split Factor2:1
Last Split DateSeptember 20, 2023